Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer.

Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer. NPJ Breast Cancer. 2019; 5:34.

View in: PubMed